U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.245C>T (p.Pro82Leu) AND Li-Fraumeni syndrome

Germline classification:
Likely benign (3 submissions)
Last evaluated:
Aug 28, 2019
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000205955.18

Allele description [Variation Report for NM_000546.6(TP53):c.245C>T (p.Pro82Leu)]

NM_000546.6(TP53):c.245C>T (p.Pro82Leu)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.245C>T (p.Pro82Leu)
Other names:
p.P82L:CCG>CTG
HGVS:
  • NC_000017.11:g.7676124G>A
  • NG_017013.2:g.16427C>T
  • NM_000546.6:c.245C>TMANE SELECT
  • NM_001126112.3:c.245C>T
  • NM_001126113.3:c.245C>T
  • NM_001126114.3:c.245C>T
  • NM_001126118.2:c.128C>T
  • NM_001276695.3:c.128C>T
  • NM_001276696.3:c.128C>T
  • NM_001276760.3:c.128C>T
  • NM_001276761.3:c.128C>T
  • NM_001407262.1:c.245C>T
  • NM_001407263.1:c.128C>T
  • NM_001407264.1:c.245C>T
  • NM_001407265.1:c.128C>T
  • NM_001407266.1:c.245C>T
  • NM_001407267.1:c.128C>T
  • NM_001407268.1:c.245C>T
  • NM_001407269.1:c.128C>T
  • NM_001407270.1:c.245C>T
  • NM_001407271.1:c.128C>T
  • NP_000537.3:p.Pro82Leu
  • NP_000537.3:p.Pro82Leu
  • NP_001119584.1:p.Pro82Leu
  • NP_001119584.1:p.Pro82Leu
  • NP_001119585.1:p.Pro82Leu
  • NP_001119585.1:p.Pro82Leu
  • NP_001119586.1:p.Pro82Leu
  • NP_001119586.1:p.Pro82Leu
  • NP_001119590.1:p.Pro43Leu
  • NP_001119590.1:p.Pro43Leu
  • NP_001263624.1:p.Pro43Leu
  • NP_001263625.1:p.Pro43Leu
  • NP_001263689.1:p.Pro43Leu
  • NP_001263690.1:p.Pro43Leu
  • NP_001394191.1:p.Pro82Leu
  • NP_001394192.1:p.Pro43Leu
  • NP_001394193.1:p.Pro82Leu
  • NP_001394194.1:p.Pro43Leu
  • NP_001394195.1:p.Pro82Leu
  • NP_001394196.1:p.Pro43Leu
  • NP_001394197.1:p.Pro82Leu
  • NP_001394198.1:p.Pro43Leu
  • NP_001394199.1:p.Pro82Leu
  • NP_001394200.1:p.Pro43Leu
  • LRG_321t1:c.245C>T
  • LRG_321t2:c.245C>T
  • LRG_321t3:c.245C>T
  • LRG_321t4:c.245C>T
  • LRG_321t7:c.-909C>T
  • LRG_321t8:c.128C>T
  • LRG_321:g.16427C>T
  • LRG_321:p.Pro82Leu
  • LRG_321p1:p.Pro82Leu
  • LRG_321p3:p.Pro82Leu
  • LRG_321p4:p.Pro82Leu
  • LRG_321p8:p.Pro43Leu
  • NC_000017.10:g.7579442G>A
  • NM_000546.4:c.245C>T
  • NM_000546.5(TP53):c.245C>T
  • NM_000546.5:c.245C>T
  • NM_001126112.2:c.245C>T
  • NM_001126113.2:c.245C>T
  • NM_001126114.2:c.245C>T
  • NM_001126117.1:c.-909C>T
  • NM_001126118.1:c.128C>T
  • NR_176326.1:n.387C>T
  • P04637:p.Pro82Leu
  • p.P82L
Protein change:
P43L
Links:
UniProtKB: P04637#VAR_044621; dbSNP: rs534447939
NCBI 1000 Genomes Browser:
rs534447939
Molecular consequence:
  • NM_000546.6:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407262.1:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407263.1:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407264.1:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407265.1:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407266.1:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407267.1:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407268.1:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407269.1:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407270.1:c.245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407271.1:c.128C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_176326.1:n.387C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
5

Condition(s)

Name:
Li-Fraumeni syndrome (LFS)
Synonyms:
Sarcoma family syndrome of Li and Fraumeni
Identifiers:
MONDO: MONDO:0018875; MedGen: C0085390; OMIM: PS151623

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000259808Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Dec 11, 2023)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

SCV001142533ClinGen TP53 Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen TP53 ACMG Specifications v1)
Likely benign
(Aug 28, 2019)
germlinecuration

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV004823828All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely Benign
(Oct 30, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown5not providednot provided108544not providedclinical testing, curation

Citations

PubMed

A novel p53 germline alteration identified in a late onset breast cancer kindred.

Sun XF, Johannsson O, Håkansson S, Sellberg G, Nordenskjöld B, Olsson H, Borg A.

Oncogene. 1996 Jul 18;13(2):407-11.

PubMed [citation]
PMID:
8710380

Next-generation sequencing in familial breast cancer patients from Lebanon.

Jalkh N, Chouery E, Haidar Z, Khater C, Atallah D, Ali H, Marafie MJ, Al-Mulla MR, Al-Mulla F, Megarbane A.

BMC Med Genomics. 2017 Feb 15;10(1):8. doi: 10.1186/s12920-017-0244-7.

PubMed [citation]
PMID:
28202063
PMCID:
PMC5312584
See all PubMed Citations (11)

Details of each submission

From Invitae, SCV000259808.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 82 of the TP53 protein (p.Pro82Leu). This variant is present in population databases (rs534447939, gnomAD 0.007%). This missense change has been observed in individual(s) with breast cancer and colon cancer (PMID: 8710380, 28202063, 33309985). ClinVar contains an entry for this variant (Variation ID: 182946). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TP53 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change does not substantially affect TP53 function (PMID: 12826609, 17606709, 20128691, 21343334, 24256616, 30224644). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ClinGen TP53 Variant Curation Expert Panel, ClinGen, SCV001142533.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)

Description

This variant has a BayesDel score < 0.16 and Align GVGD (Zebrafish) is Class C0 or Class C15 (BP4). Additionally, transactivation assays show retained function according to Kato, et al. and there is no evidence of a dominant negative effect or loss of function according to Giacomelli, et al. (BS3; PMID: 12826609, 30224644). In summary, TP53 c.245C>T; p.Pro82Leu meets criteria to be classified as likely benign for Li-Fraumeni syndrome. ACMG/AMP criteria applied, as specified by the TP53 Variant Curation Expert Panel: BP4 and BS3.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004823828.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided5not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided5not providednot providednot provided

Last Updated: May 26, 2024